CING
Price
$4.16
Change
-$0.09 (-2.12%)
Updated
Apr 2, 04:59 PM (EDT)
Capitalization
15.5M
SNBIF
Price
$6.55
Change
+$1.90 (+40.86%)
Updated
Feb 12 closing price
Capitalization
786.2M
Ad is loading...

CING vs SNBIF

Header iconCING vs SNBIF Comparison
Open Charts CING vs SNBIFBanner chart's image
Cingulate
Price$4.16
Change-$0.09 (-2.12%)
VolumeN/A
Capitalization15.5M
Sanbio
Price$6.55
Change+$1.90 (+40.86%)
Volume$200
Capitalization786.2M
CING vs SNBIF Comparison Chart
Loading...
CING
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CING vs. SNBIF commentary
Apr 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CING is a Hold and SNBIF is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 03, 2025
Stock price -- (CING: $4.25 vs. SNBIF: $6.55)
Brand notoriety: CING and SNBIF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CING: 106% vs. SNBIF: 32%
Market capitalization -- CING: $15.5M vs. SNBIF: $802.24M
CING [@Biotechnology] is valued at $15.5M. SNBIF’s [@Biotechnology] market capitalization is $802.24M. The market cap for tickers in the [@Biotechnology] industry ranges from $302.51B to $0. The average market capitalization across the [@Biotechnology] industry is $2.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CING’s FA Score shows that 0 FA rating(s) are green whileSNBIF’s FA Score has 0 green FA rating(s).

  • CING’s FA Score: 0 green, 5 red.
  • SNBIF’s FA Score: 0 green, 5 red.
According to our system of comparison, both CING and SNBIF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CING’s TA Score shows that 4 TA indicator(s) are bullish.

  • CING’s TA Score: 4 bullish, 5 bearish.

Price Growth

CING (@Biotechnology) experienced а +6.25% price change this week, while SNBIF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -5.27%. For the same industry, the average monthly price growth was -7.37%, and the average quarterly price growth was -12.08%.

Reported Earning Dates

CING is expected to report earnings on Mar 08, 2024.

Industries' Descriptions

@Biotechnology (-5.27% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SNBIF($786M) has a higher market cap than CING($15.5M). SNBIF YTD gains are higher at: 40.860 vs. CING (-13.793). CING has higher annual earnings (EBITDA): -15.57M vs. SNBIF (-1.57B). SNBIF has more cash in the bank: 3.96B vs. CING (10M). CING has less debt than SNBIF: CING (234K) vs SNBIF (598M). CING (0) and SNBIF (0) have equivalent revenues.
CINGSNBIFCING / SNBIF
Capitalization15.5M786M2%
EBITDA-15.57M-1.57B1%
Gain YTD-13.79340.860-34%
P/E RatioN/AN/A-
Revenue00-
Total Cash10M3.96B0%
Total Debt234K598M0%
FUNDAMENTALS RATINGS
SNBIF: Fundamental Ratings
SNBIF
OUTLOOK RATING
1..100
41
VALUATION
overvalued / fair valued / undervalued
1..100
95
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
61
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CING
RSI
ODDS (%)
Bullish Trend 2 days ago
79%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
86%
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 7 days ago
81%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
CING
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GCAEX5.80N/A
N/A
Gabelli Equity Income A
REPIX42.32N/A
N/A
ProFunds Real Estate UltraSector Inv
TFOIX35.85N/A
N/A
Transamerica Capital Growth I
JDISX14.50N/A
N/A
JHancock Disciplined Value Intl R2
TAGFX9.31N/A
N/A
Transamerica Mid Cap Growth R6

CING and

Correlation & Price change

A.I.dvisor indicates that over the last year, CING has been loosely correlated with GOVX. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if CING jumps, then GOVX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CING
1D Price
Change %
CING100%
-1.16%
GOVX - CING
34%
Loosely correlated
+1.89%
BEIGF - CING
29%
Poorly correlated
N/A
ELVN - CING
29%
Poorly correlated
-4.07%
SLNO - CING
28%
Poorly correlated
-4.46%
SNBIF - CING
28%
Poorly correlated
N/A
More

SNBIF and

Correlation & Price change

A.I.dvisor indicates that over the last year, SNBIF has been loosely correlated with HRMY. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if SNBIF jumps, then HRMY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNBIF
1D Price
Change %
SNBIF100%
N/A
HRMY - SNBIF
52%
Loosely correlated
-2.32%
QRON - SNBIF
34%
Loosely correlated
N/A
CING - SNBIF
28%
Poorly correlated
-1.16%
WXXWY - SNBIF
28%
Poorly correlated
-1.15%
EDSA - SNBIF
25%
Poorly correlated
-4.92%
More